(Q48175705)

9 February 2018

title

Fluoxetine partly exerts its actions through GABA: a neurochemical evidence. (English)

1 reference

9 February 2018

1 reference

M Zafer Gören

1

1 reference

9 February 2018

Esra Küçükibrahimoglu

series ordinal

2

1 reference

9 February 2018

Kemal Berkman

series ordinal

3

1 reference

9 February 2018

Berna Terzioglu

series ordinal

4

1 reference

9 February 2018

publication date

8 May 2007

1 reference

9 February 2018

published in

Neurochemical Research

1 reference

9 February 2018

volume

32

1 reference

9 February 2018

issue

9

1 reference

9 February 2018

page(s)

1559-1565

1 reference

9 February 2018

https://scigraph.springernature.com/pub.10.1007/s11064-007-9357-2

exact match

0 references

cites work

Fluoxetine: a serotonin-specific, second-generation antidepressant

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11064-007-9357-2

Small-dose ketamine improves the postoperative state of depressed patients

21 January 2018

1 reference

12 December 2020

Brain GABAA/benzodiazepine binding sites and glutamic acid decarboxylase activity in depressed suicide victims

1 reference

12 December 2020

GABAB receptor mRNA in the raphe nuclei: co-expression with serotonin transporter and glutamic acid decarboxylase

1 reference

12 December 2020

Gamma-aminobutyric acid-B (GABAB) binding sites in postmortem suicide brains.

1 reference

12 December 2020

Involvement of GABA(B) receptor systems in action of antidepressants: baclofen but not bicuculline attenuates the effects of antidepressants on the forced swim test in rats.

1 reference

12 December 2020

Antidepressants and the risk of suicidal behaviors

1 reference

12 December 2020

Evidence for G protein mediation of serotonin- and GABAB-induced hyperpolarization of rat dorsal raphe neurons.

1 reference

12 December 2020

GABA uptake sites in frontal cortex from suicide victims and in aging.

1 reference

12 December 2020

Benzodiazepine receptors in the post-mortem brain of suicide victims and schizophrenic subjects.

1 reference

12 December 2020

Benign course in a child with a massive fluoxetine overdose.

1 reference

12 December 2020

The GABA(B) receptor antagonist CGP36742 improves learned helplessness in rats.

1 reference

12 December 2020

Report of a fluoxetine fatality

1 reference

12 December 2020

Cortical gamma-aminobutyric acid concentrations in depressed patients receiving cognitive behavioral therapy

1 reference

12 December 2020

GABA concentrations in forebrain areas of suicide victims.

1 reference

12 December 2020

Increased cerebrospinal fluid glutamine levels in depressed patients

1 reference

12 December 2020

Plasma concentrations of gamma-aminobutyric acid (GABA) and mood disorders: a blood test for manic depressive disease?

1 reference

12 December 2020

Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression

1 reference

12 December 2020

Low plasma gamma-aminobutyric acid levels in male patients with depression.

1 reference

12 December 2020

The effects of compounds acting at the benzodiazepine receptor complex on the ultrasonic calling of mouse pups.

1 reference

12 December 2020

Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines

1 reference

12 December 2020

Antidepressant effects of ketamine in depressed patients

1 reference

12 December 2020

Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake

1 reference

12 December 2020

Neuropharmacological effects of low and high doses of repeated oral dexfenfluramine in rats: a comparison with fluoxetine.

1 reference

12 December 2020

Altered response to benzodiazepine anxiolytics in mice lacking GABA B(1) receptors

1 reference

12 December 2020

GABAergic influences on plus-maze behaviour in mice.

1 reference

12 December 2020

Depression among alcoholics. Relationship to clinical and cerebrospinal fluid variables

1 reference

12 December 2020

Effect of GABAergic drugs in the behavioral 'despair' test in rats

1 reference

12 December 2020

Don't worry 'B' happy!: a role for GABA(B) receptors in anxiety and depression.

1 reference

12 December 2020

GABAB receptor antagonist-mediated antidepressant-like behavior is serotonin-dependent.

1 reference

12 December 2020

Cerebrospinal fluid GABA levels in chronic migraine with and without depression.

1 reference

12 December 2020

Decreased density of peripheral benzodiazepine receptors in psychiatric patients after a suicide attempt

1 reference

12 December 2020

Fluoxetine versus tricyclic antidepressants: a prospective multicenter study of antidepressant drug overdoses. The Antidepressant Study Group

1 reference

12 December 2020

The benzodiazepine binding site of GABA A receptors as a target for the development of novel anxiolytics

1 reference

12 December 2020

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

1 reference

12 December 2020

The GABA(B) receptor antagonist CGP36742 attenuates the baclofen- and scopolamine-induced deficit in Morris water maze task in rats

1 reference

12 December 2020

Cerebrospinal fluid gamma-aminobutyric acid and homovanillic acid in depressive disorders

1 reference

12 December 2020

GABA(B) receptors in 5-HT transporter- and 5-HT1A receptor-knock-out mice: further evidence of a transduction pathway shared with 5-HT1A receptors.

1 reference

12 December 2020

Anxioselective compounds acting at the GABA(A) receptor benzodiazepine binding site

1 reference

12 December 2020

Monoamine reuptake inhibitors enhance the discriminative state induced by cocaine in the rat

1 reference

12 December 2020

Olanzapine and fluoxetine administration and coadministration increase rat hippocampal pregnenolone, allopregnanolone and peripheral deoxycorticosterone: implications for therapeutic actions.

1 reference

12 December 2020

Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors

1 reference

12 December 2020

Fengabine, a new GABAmimetic agent in the treatment of depressive disorders: an overview of six double-blind studies versus tricyclics

1 reference

12 December 2020

Clinical relevance of measuring GABA concentrations in cerebrospinal fluid

1 reference

12 December 2020

10.1007/S11064-007-9357-2

Identifiers

DOI

1 reference

9 February 2018

PubMed ID

17486443

1 reference

9 February 2018